Window Study of SAR439859 Versus Letrozole in ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
Window Study of SAR439859 Versus Letrozole in ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
Trial Category:
Breast
Phase
II
Contact(s)
Location(s)
Nebraska Hematology Oncology, Lincoln, NE
